← All trials
NCT04891133
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 3, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2025
- First posted
- May 18, 2021
- Last posted
- Sep 13, 2021
- Enrollment
- 1900
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OsloLead sponsor
- University of OsloReponsible party - principal investigator
- Institut National de la Santé Et de la Recherche Médicale, FranceStudy chair
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- Epidemiological and Clinical Research Information NetworkCollaborator
- Autonomous University of MadridOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.